4.7 Letter

Systemic Corticosteroid Use for COVID-19 in US Outpatient Settings From April 2020 to August 2021

Journal

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Volume 327, Issue 20, Pages 2015-2018

Publisher

AMER MEDICAL ASSOC
DOI: 10.1001/jama.2022.4877

Keywords

-

Funding

  1. US Food and Drug Administration (FDA) [21-182]
  2. Centers for Medicare AMP
  3. Medicaid Services (CMS) [75FCMC21F0067]
  4. FDA
  5. Centers for Drug Evaluation and Research [75F40119D10037]
  6. US Department of Health and Human Services (DHHS) [75F40119F19001]

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Risk of diabetes complications among those with diabetes receiving androgen deprivation therapy for localized prostate cancer

Marie C. Bradley, Yingjun Zhou, Andrew N. Freedman, Marianne Ulcickas Yood, Charles P. Quesenbery, Reina Haque, Stephen K. Van den Eeden, Andrea E. Cassidy-Bushrow, David Aaronson, Arnold L. Potosky

CANCER CAUSES & CONTROL (2018)

Article Oncology

Domperidone use and risk of primary liver cancer in the Clinical Practice Research Datalink

Jake E. Thistle, Jessica L. Petrick, Baiyu Yang, Marie C. Bradley, Barry Graubard, Katherine A. McGlynn

CANCER EPIDEMIOLOGY (2018)

Article Public, Environmental & Occupational Health

Oophorectomy and risk of non-alcoholic fatty liver disease and primary liver cancer in the Clinical Practice Research Datalink

Andrea A. Florio, Barry I. Graubard, Baiyu Yang, Jake E. Thistle, Marie C. Bradley, Katherine A. McGlynn, Jessica L. Petrick

EUROPEAN JOURNAL OF EPIDEMIOLOGY (2019)

Article Endocrinology & Metabolism

Similar Breast Cancer Risk in Women Older Than 65 Years Initiating Glargine, Detemir, and NPH Insulins

Marie C. Bradley, Yoganand Chillarige, Hana Lee, Xiyuan Wu, Shruti Parulekar, Michael Wernecke, Patricia Bright, Mat Soukup, Thomas E. MaCurdy, Jeffrey A. Kelman, David J. Graham

DIABETES CARE (2020)

Article Urology & Nephrology

Trends and Patterns of Testosterone Therapy among US Male Medicare Beneficiaries, 1999 to 2014

Cindy Ke Zhou, Shailesh Advani, Matthew Chaloux, James Todd Gibson, Mandi Yu, Marie Bradley, Robert N. Hoover, Michael B. Cook

JOURNAL OF UROLOGY (2020)

Article Allergy

Risk of Psychiatric Adverse Events Among Montelukast Users

Veronica Sansing-Foster, Nicole Haug, Andrew Mosholder, Noelle M. Cocoros, Marie Bradley, Yong Ma, Dinci Pennap, Elizabeth C. Dee, Sengwee Toh, Ella Pestine, Andrew B. Petrone, Ivone Kim, Jennifer G. Lyons, Efe Eworuke

Summary: The study found no associations between montelukast use and hospitalizations for depression or self-harm events compared to ICS use. Most psychiatric adverse events occurred in patients with a past psychiatric history.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)

Article Geriatrics & Gerontology

Potentially inappropriate prescribing in dementia, multi-morbidity and incidence of adverse health outcomes

Joao Delgado, Lindsay Jones, Marie C. Bradley, Louise M. Allan, Clive Ballard, Linda Clare, Richard H. Fortinsky, Carmel M. Hughes, David Melzer

Summary: The study found that patients with dementia often receive potentially inappropriate prescribing (PIP), which increases the risk of adverse health outcomes such as mortality, skin issues, falls, anemia, and osteoporosis. This highlights the importance of optimizing medication in dementia patients, especially those with comorbidities.

AGE AND AGEING (2021)

Article Health Care Sciences & Services

Risk of Stroke and Bleeding in Atrial Fibrillation Treated with Apixaban Compared with Warfarin

Marie Bradley, Emily C. Welch, Efe Eworuke, David J. Graham, Rongmei Zhang, Ting-Ying Huang

JOURNAL OF GENERAL INTERNAL MEDICINE (2020)

Article Medicine, General & Internal

Severe Hypoglycemia Risk With Long-Acting Insulin Analogs vs Neutral Protamine Hagedorn Insulin

Marie C. Bradley, Yoganand Chillarige, Hana Lee, Xiyuan Wu, Shruti Parulekar, Stella Muthuri, Michael Wernecke, Thomas E. MaCurdy, Jeffrey A. Kelman, David J. Graham

Summary: Previous studies have shown that the risk of severe hypoglycemia does not differ between long-acting insulin analogs and NPH insulin in patients with type 2 diabetes. This study focused on older patients and found that initiation of long-acting insulin analogs was associated with a lower risk of ED visits or hospitalizations for hypoglycemia compared with NPH insulin, especially for recurrent events.

JAMA INTERNAL MEDICINE (2021)

Article Medicine, General & Internal

Deintensification of Treatment With Sulfonylurea and Insulin After Severe Hypoglycemia Among Older Adults With Diabetes

Anastasia-Stefania Alexopoulos, Anna R. Kahkoska, Virginia Pate, Marie C. Bradley, Joshua Niznik, Carolyn Thorpe, Til Stuermer, John Buse

Summary: In this study, deintensification of sulfonylurea and/or insulin therapy within 100 days after a hypoglycemia-associated ED visit or hospitalization occurred in fewer than 50% of older adults with diabetes. These deintensification rates may be increasing over time, suggesting that greater efforts are needed to identify individuals at high risk of hypoglycemia and encourage appropriate treatment deintensification according to current evidence.

JAMA NETWORK OPEN (2021)

Article Public, Environmental & Occupational Health

Categorization of COVID-19 severity to determine mortality risk

Elizabeth M. Garry, Andrew R. Weckstein, Kenneth Quinto, Marie C. Bradley, Tamar Lasky, Aloka Chakravarty, Sandy Leonard, Sarah E. Vititoe, Imaani J. Easthausen, Jeremy A. Rassen, Nicolle M. Gatto

Summary: This study developed an algorithm for classifying the severity of hospitalized COVID-19 patients based on respiratory support requirements, and found a positive association between the algorithm-defined severity and 28-day mortality risk and rate.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2022)

Article Immunology

A Descriptive Cohort Study of Drug Utilization Patterns Among Patients Hospitalized With Coronavirus Disease 2019 in the United States, January 2021-February 2022

Sarah E. Vititoe, Priya Govil, Aidan Baglivo, Elisha Beebe, Elizabeth M. Garry, Nicolle M. Gatto, Tamar Lasky, Aloka Chakravarty, Marie C. Bradley, Silvia Perez-Vilar, Donna R. Rivera, Kenneth Quinto, Andrew Clerman, Anil Rajpal, Vera Frajzyngier

Summary: This study describes the utilization patterns of medications for COVID-19 treatment among hospitalized adults. The findings indicate that corticosteroids were the most commonly used initial medications, and IL-6 inhibitors and Janus kinase inhibitors were frequently administered in combination with corticosteroids and remdesivir. These findings provide important context for ongoing comparative studies of COVID-19 treatments.

OPEN FORUM INFECTIOUS DISEASES (2023)

Article Oncology

Risk of Nonmelanoma Skin Cancer in Association With Use of Hydrochlorothiazide-Containing Products in the United States

Efe Eworuke, Nicole Haug, Marie Bradley, Austin Cosgrove, Tancy Zhang, Elizabeth C. Dee, Sruthi Adimadhyam, Andrew Petrone, Hana Lee, Tiffany Woodworth, Sengwee Toh

Summary: The study found that there was no significant difference in the risk of basal cell carcinoma between HCTZ and ACEI users in the US population, but there was an increased risk of squamous cell carcinoma associated with HCTZ use. Particularly among Caucasians, HCTZ users faced higher risks of both BCC and SCC.

JNCI CANCER SPECTRUM (2021)

Letter Medicine, General & Internal

Systemic Corticosteroid Use for COVID-19 in US Outpatient Settings From April 2020 to August 2021

Marie C. Bradley, Silvia Perez-Vilar, Yoganand Chillarige, Diane Dong, Ashley I. Martinez, Andrew R. Weckstein, Gerald J. Dal Pan

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

No Data Available